Matches in Nanopublications for { ?s ?p "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1222134.RAkhz5O9XVZJdVn1UafKfBqAfvkb6-7VdeJw_FvEALeBo130_assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222134.RAkhz5O9XVZJdVn1UafKfBqAfvkb6-7VdeJw_FvEALeBo130_provenance.
- NP1222137.RAiYcqwOS64o2C-IBEV4pwDp2WsUCgag3PGQJUbn6iO7U130_assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222137.RAiYcqwOS64o2C-IBEV4pwDp2WsUCgag3PGQJUbn6iO7U130_provenance.
- NP1222136.RAMagnxLhFNC2IOqCcUHXM-Z6CN1jV2K1JAv6P-S-R78Y130_assertion description "[Interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib were examined in non-Hodgkin lymphoma (NHL) models, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and double-hit lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222136.RAMagnxLhFNC2IOqCcUHXM-Z6CN1jV2K1JAv6P-S-R78Y130_provenance.